Picard Medical, Inc.
PMI
$7.60
$0.000.00%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -45.90% | -12.93% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -45.90% | -12.93% | -- | -- | -- |
| Cost of Revenue | -37.77% | -40.70% | -- | -- | -- |
| Gross Profit | 3.26% | 95.61% | -- | -- | -- |
| SG&A Expenses | -1.08% | -6.90% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.03% | -11.89% | -- | -- | -- |
| Operating Income | -7.03% | 11.55% | -- | -- | -- |
| Income Before Tax | -73.92% | -35.32% | -- | -- | -- |
| Income Tax Expenses | 900.00% | -650.00% | -- | -- | -- |
| Earnings from Continuing Operations | -74.06% | -35.24% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.06% | -35.24% | -- | -- | -- |
| EBIT | -7.03% | 11.55% | -- | -- | -- |
| EBITDA | -10.64% | 9.59% | -- | -- | -- |
| EPS Basic | -64.99% | -31.85% | -- | -- | -- |
| Normalized Basic EPS | -74.41% | -35.32% | -- | -- | -- |
| EPS Diluted | -64.99% | -31.85% | -- | -- | -- |
| Normalized Diluted EPS | -74.41% | -35.32% | -- | -- | -- |
| Average Basic Shares Outstanding | 0.06% | 0.00% | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.06% | 0.00% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |